Callitas Health Inc. Aktie Deutsche Boerse AG
Aktien
A2GSU1
CA13125C1068
T3F3
Biotechnologie
Umsatz 2018 | 0.75 0.69 0.67 | Umsatz 2019 | 0.71 0.65 0.63 | Marktwert | 3.53 Mio. 3.25 Mio. 3.16 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -5 Mio. -4.61 Mio. -4.48 Mio. | Nettoergebnis 2019 | -1 Mio. -922’765 -895’100 | EV / Sales 2018 | 4’852’616 x |
Nettoschuld 2018 | 318’990 294’353 285’528 | Nettoschuld 2019 | 847’693 782’221 758’770 | EV / Sales 2019 | 6’168’166 x |
KGV 2018 |
-0.6
x | KGV 2019 |
-1.97
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 72.04% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | - | 03.01.18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01.12.14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
% 1. Jan. | Kap. | |
---|---|---|
+18.97% | 44.44 Mrd. | |
+41.98% | 40.03 Mrd. | |
-10.06% | 37.68 Mrd. | |
+31.15% | 31.46 Mrd. | |
-7.79% | 27.29 Mrd. | |
+13.32% | 26.29 Mrd. | |
+43.05% | 13.8 Mrd. | |
+31.28% | 12.46 Mrd. | |
-7.41% | 11.26 Mrd. |